Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.67 | N/A |
| PEG Ratio (TTM) | -3.19 | N/A |
| P/S Ratio (TTM) | 2.45 | N/A |
| P/B Ratio (TTM) | 1.98 | N/A |
| P/FCF Ratio (TTM) | -13.80 | N/A |
| Price to 5YR AVG Earnings Ratio | 34.11 | N/A |
| Price to 5YR AVG FCF Ratio | -13.55 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.25% | N/A |
| ROE (TTM) | 9.50% | N/A |
| Net Profit Margin (TTM) | 11.25% | N/A |
| ROIC 5YR AVG | 4.47% | N/A |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.32% | 27.46% | 21.92% |
| Revenue | 1.88% | -5.97% | -2.60% |
| Net Income | 0.04% | 51.09% | 39.65% |
| Cash Flow | -16.27% | -33.47% | 1,628.21% |
Health (25%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.11 | N/A |
| Quick Ratio (TTM) | 0.92 | N/A |
| D/E Ratio (TTM) | 1.89 | N/A |
| Interest Coverage (TTM) | 2.24 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.79 | N/A |
| LTL to 5YR AVG FCF | -11.34 | N/A |
| Shares Outstanding Growth 5YR AVG | 7.14% | N/A |